Poran, Ernisto .
HRN: 15-95-21 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/31/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
03/31/2024
04/07/2024
IV
4.5g
Q6hours
Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes